These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18846602)

  • 1. Head-to-head right-handed cross-links of the antitumor-active bis(mu-N,N'-di-p-tolylformamidinato)dirhodium(II,II) unit with the dinucleotides d(GpA) and d(ApG).
    Chifotides HT; Dunbar KR
    Chemistry; 2008; 14(32):9902-13. PubMed ID: 18846602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unprecedented head-to-head right-handed cross-links between the antitumor bis(mu-N,N'-di-p-tolylformamidinate) dirhodium(II,II) core and the dinucleotide d(ApA) with the adenine bases in the rare imino form.
    Chifotides HT; Dunbar KR
    J Am Chem Soc; 2007 Oct; 129(41):12480-90. PubMed ID: 17883272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-head cross-linked adduct between the antitumor unit bis(mu-N,N'-di-p-tolylformamidinato)dirhodium(II,II) and the DNA fragment d(GpG).
    Chifotides HT; Dunbar KR
    Chemistry; 2006 Aug; 12(25):6458-68. PubMed ID: 16900545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel binding interactions of the DNA fragment d(pGpG) cross-linked by the antitumor active compound tetrakis(mu-carboxylato)dirhodium(II,II).
    Chifotides HT; Koshlap KM; Pérez LM; Dunbar KR
    J Am Chem Soc; 2003 Sep; 125(35):10714-24. PubMed ID: 12940757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unprecedented head-to-head conformers of d(GpG) bound to the antitumor active compound tetrakis (mu-carboxylato)dirhodium(II,II).
    Chifotides HT; Koshlap KM; Pérez LM; Dunbar KR
    J Am Chem Soc; 2003 Sep; 125(35):10703-13. PubMed ID: 12940756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2D NMR study of the DNA duplex d(CTCTC*A*ACTTCC).d(GGAAGTTGAGAG) cross-linked by the antitumor-active dirhodium(II,II) unit at the cytosine-adenine step.
    Kang M; Chifotides HT; Dunbar KR
    Biochemistry; 2008 Feb; 47(8):2265-76. PubMed ID: 18232716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dirhodium formamidinate compounds with bidentate nitrogen chelating ligands.
    Chifotides HT; Catalan KV; Dunbar KR
    Inorg Chem; 2003 Dec; 42(26):8739-47. PubMed ID: 14686852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential DNA recognition by the enantiomers of 1-Rh(MGP)2 phi: a combination of shape selection and direct readout.
    Franklin SJ; Barton JK
    Biochemistry; 1998 Nov; 37(46):16093-105. PubMed ID: 9819202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of DNA purine sites to dirhodium compounds probed by mass spectrometry.
    Chifotides HT; Koomen JM; Kang M; Tichy SE; Dunbar KR; Russell DH
    Inorg Chem; 2004 Oct; 43(20):6177-87. PubMed ID: 15446862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computational study on DNA bases interactions with dinuclear tetraacetato-diaqua-dirhodium(II,II) complex.
    Burda JV; Gu J
    J Inorg Biochem; 2008 Jan; 102(1):53-62. PubMed ID: 17698203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic coordination chemistry relevant to DNA adducts formed by the cisplatin anticancer drug. NMR studies on compounds with sterically crowded chiral ligands.
    Saad JS; Benedetti M; Natile G; Marzilli LG
    Inorg Chem; 2010 Jun; 49(12):5573-83. PubMed ID: 20496875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR studies of models having the Pt(d(GpG)) 17-membered macrocyclic ring formed in DNA by platinum anticancer drugs: Pt complexes with bulky chiral diamine ligands.
    Saad JS; Benedetti M; Natile G; Marzilli LG
    Inorg Chem; 2011 May; 50(10):4559-71. PubMed ID: 21510625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origins of the distortions in the base pair step adjacent to platinum anticancer drug-DNA adducts. Fundamental NMR solution studies utilizing right-handed cross-link models having 5'- and 3'-flanking residues.
    Saad JS; Natile G; Marzilli LG
    J Am Chem Soc; 2009 Sep; 131(34):12314-24. PubMed ID: 19655752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding interaction of [Re(H2O)3(CO)3]+ with the DNA fragment d(CpGpG).
    Zobi F; Blacque O; Sigel RK; Alberto R
    Inorg Chem; 2007 Dec; 46(25):10458-60. PubMed ID: 18001120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray structural characterization of the bis-guanine derivative of a cisplatin analogue having just one proton on each coordinated nitrogen and a head-to-head conformation: [Pt{(+/-)-N,N'-dimethyl-2,3-diaminobutane}(9-ethyl-guanine)2]dinitrate.
    Intini FP; Cini R; Tamasi G; Hursthouse MB; Marzilli LG; Natile G
    Inorg Chem; 2010 Sep; 49(17):7853-60. PubMed ID: 20799737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of transcription in vitro by anticancer active dirhodium(II) complexes.
    Sorasaenee K; Fu PK; Angeles-Boza AM; Dunbar KR; Turro C
    Inorg Chem; 2003 Feb; 42(4):1267-71. PubMed ID: 12588165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent binding and interstrand cross-linking of duplex DNA by dirhodium(II,II) carboxylate compounds.
    Dunham SU; Chifotides HT; Mikulski S; Burr AE; Dunbar KR
    Biochemistry; 2005 Jan; 44(3):996-1003. PubMed ID: 15654756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation relevant to the conformation of the 17-membered Pt(d(GpG)) macrocyclic ring formed by Pt anticancer drugs with DNA: Pt complexes with a Goldilocks carrier ligand.
    Maheshwari V; Marzilli PA; Marzilli LG
    Inorg Chem; 2011 Jul; 50(14):6626-36. PubMed ID: 21667929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism and control of rare tautomer trapping at a metal-metal bond: adenine binding to dirhodium antitumor agents.
    Deubel DV
    J Am Chem Soc; 2008 Jan; 130(2):665-75. PubMed ID: 18085779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-stranded oligonucleotide adducts formed by Pt complexes favoring left-handed base canting: steric effect of flanking residues and relevance to DNA adducts formed by Pt anticancer drugs.
    Saad JS; Marzilli PA; Intini FP; Natile G; Marzilli LG
    Inorg Chem; 2011 Sep; 50(17):8608-20. PubMed ID: 21819051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.